There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Precision BioSciences (DTIL – Research Report) and Oramed Pharmaceuticals (ORMP – Research Report) with bullish sentiments.
Precision BioSciences (DTIL)
In a report issued on August 11, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Precision BioSciences, with a price target of $9.00. The company’s shares closed last Friday at $2.01, close to its 52-week low of $1.11.
According to TipRanks.com, Burnett ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Precision BioSciences has an analyst consensus of Moderate Buy, with a price target consensus of $9.00, implying a 448.8% upside from current levels. In a report issued on August 8, JonesTrading also maintained a Buy rating on the stock with a $8.00 price target.
See the top stocks recommended by analysts >>
Oramed Pharmaceuticals (ORMP)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oramed Pharmaceuticals today and set a price target of $32.00. The company’s shares closed last Friday at $9.48.
According to TipRanks.com, Selvaraju has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Oramed Pharmaceuticals with a $31.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DTIL:
- H.C. Wainwright Reaffirms Their Buy Rating on Urogen Pharma (URGN)
- Stifel Nicolaus Sticks to Their Buy Rating for Vertex Energy (VTNR)
- Analysts Offer Insights on Healthcare Companies: Evofem Biosciences (OtherEVFM), Greenwich LifeSciences (GLSI) and Chinook Therapeutics (KDNY)
- Titanium Transportation Group Announces Appointment of Grace Palombo to Board of Directors
- Shoals Technologies Group Further Strengthens Executive Management Team With Appointment of New Chief Financial Officer
